Columbia Capital’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Columbia Capital’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$998K	Buy	+18,494	New	+$1.01M	1.09%	30
2014 Q3	–	Sell	-6,024	Closed	-$313K	–	72
2014 Q2	$313K	Buy	6,024 +18	+0.3%	+$868	0.25%	60
2014 Q1	$275K	Hold	6,006	–	–	0.2%	73
2013 Q4	$265K	Buy	6,006 +106	+2%	+$4.41K	0.23%	57
2013 Q3	$227K	Buy	5,900 +16	+0.3%	+$605	0.2%	56
2013 Q2	$207K	Buy	+5,884	New	+$199K	0.21%	51

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return

Columbia Capital's XPH Position: Q4 2014 in Review

Columbia Capital opened a new position in State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2014: 18,494 shares worth $998K. The stake represents 1.09% of the portfolio and ranks #30 among its holdings. This is a return to the name: Columbia Capital previously reported a position in XPH as recently as Q2 2014.

Columbia Capital first reported a position in XPH in Q2 2013 and has held it in 6 quarters since. 78 funds tracked by Wall St. Rank hold XPH as of Q4 2014.

Columbia Capital held 18,494 shares of State Street SPDR S&P Pharmaceuticals ETF worth $998K as of Q4 2014.
State Street SPDR S&P Pharmaceuticals ETF was a new Columbia Capital position in Q4 2014.
State Street SPDR S&P Pharmaceuticals ETF made up 1.09% of Columbia Capital's portfolio in Q4 2014, its #30 holding.
Columbia Capital first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2013 and has held it in 6 quarters since.
78 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2014.

Based on Columbia Capital's 13F filing for Q4 2014, filed 11 Feb 2015.